June 15, 2026
You were told your ALT was elevated. You reduced alcohol to zero, improved your diet, started exercising regularly. Three months later, your enzymes are still elevated — perhaps slightly better, perhaps unchanged. Your doctor seems puzzled. You are frustrated. This pattern is common enough at ALIV's Pune and Mumbai clinics that it deserves a structured clinical explanation.
The standard advice for elevated liver enzymes is to "eat healthy and reduce fatty foods." This advice, while directionally correct, is insufficiently specific to drive meaningful improvement in most patients with MASLD. The primary driver of hepatic fat accumulation in most Indian patients is not dietary fat per se — it is excess fructose and refined carbohydrates that drive de novo lipogenesis in the liver. A patient who eliminates fried food but continues drinking fruit juice daily, eating white rice at every meal, and consuming tea with significant added sugar has made genuine effort but has not addressed the primary dietary driver. The dietary change that moves liver enzymes requires specifically reducing added sugars, fructose-containing beverages, and refined grain load — not simply switching to a "healthy" eating pattern that still contains high glycaemic carbohydrates.
Supplements and herbal medications. This is consistently underexplored in Indian clinical practice. A significant number of herbal and ayurvedic preparations contain hepatotoxic compounds at doses commonly used. Patients who have begun a "liver cleanse" supplement alongside dietary change may be counterproductively adding hepatic stress while believing they are supporting liver recovery. Every supplement and herbal product in regular use should be reviewed and most halted for a trial period when liver enzymes are persistently elevated. Read: liver detox supplements — what's risky.
Medications contributing to enzyme elevation. Statins, methotrexate, anti-tuberculosis medications, and many other drugs commonly used in urban India produce measurable ALT elevation. If a new medication was started around the time liver enzymes first elevated and has not been considered in the workup, this is an important variable to assess with the prescribing physician.
Undiagnosed autoimmune hepatitis or coeliac disease. As discussed in our elevated liver enzyme causes guide, autoimmune hepatitis and coeliac disease can both produce persistent mild enzyme elevation that dietary change alone does not address. These require specific serological testing to identify.
Thyroid dysfunction. Hypothyroidism directly impairs lipid metabolism and can maintain hepatic steatosis and enzyme elevation independently of dietary effort. Testing TSH, free T3, and free T4 is essential in the workup of persistent liver enzyme elevation that has not responded to lifestyle change.
The timeline is insufficient. Fatty liver reversal is a months-long process. Three months of consistent change is a start — but for patients with Grade 2 or 3 fatty liver, meaningful enzyme normalisation may take six to twelve months of sustained effort. If the timeline of expectation is shorter than the biology allows, apparent non-response may simply be insufficient time.
If liver enzymes remain above 1.5 to 2 times normal after six months of genuine, specific, consistent dietary change — with alcohol excluded, supplements reviewed, and medications assessed — a specialist hepatology referral is appropriate. Fibroscan to assess fibrosis, liver biopsy if indicated, and a comprehensive specialist review may reveal a cause that the initial workup missed. Read the complete picture: liver health and fatty liver pillar.
For Grade 1 fatty liver with mild ALT elevation: four to eight weeks of specific, sustained dietary change often produces measurable improvement. For Grade 2–3 with more significant elevation: three to six months is a more realistic timeline before significant normalisation, and some patients require six to twelve months. The degree of elevation, severity of the underlying condition, and how completely the dietary drivers are addressed all influence the timeline.
Chronic psychological stress does not directly elevate liver enzymes — but it contributes to the cortisol-driven insulin resistance and visceral fat accumulation that drives MASLD, making it harder to achieve the metabolic improvement that would allow enzyme normalisation. Stress management is relevant to liver health through its metabolic effects rather than through a direct hepatic mechanism.
Do not stop a statin without speaking to your prescribing doctor. Statin-related liver enzyme elevation is usually mild and self-limiting. Significant statin-related hepatotoxicity is rare. The clinical decision about whether to continue, switch to a different statin, or stop is made by weighing the cardiovascular benefit of the statin against the degree and pattern of enzyme elevation. This is a conversation for your prescribing physician, not a self-management decision.
The glutathione and antioxidant components of the ALIV Liver Health & Detox IV may support liver cell recovery in patients where oxidative stress is a significant contributor — as it commonly is in MASLD. For patients where the enzyme elevation has a dietary or metabolic driver that is actively being addressed, IV liver support as an adjunct is clinically reasonable. It is not a substitute for identifying and addressing the actual cause of persistent elevation.
Eliminating added sugar — including fruit juice, sugar in tea and coffee, sweetened beverages, and refined confectionery — has the most specific and well-documented impact on hepatic fat reduction of any single dietary intervention. This targets the fructose load that drives de novo lipogenesis in the liver most directly. Combined with reducing refined grain intake (white rice, maida, white bread), this dietary change produces more consistent liver enzyme improvement than generic "healthy eating" recommendations.